GOLDMAN SACHS GROUP INC - SQZ BIOTECHNOLOGIES CO ownership

SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 48 filers reported holding SQZ BIOTECHNOLOGIES CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SQZ BIOTECHNOLOGIES CO
ValueSharesWeighting
Q2 2023$4,292
-48.5%
15,896
+6.8%
0.00%
Q1 2023$8,335
-38.1%
14,884
-18.2%
0.00%
Q4 2022$13,468
-76.8%
18,200
-29.4%
0.00%
Q3 2022$58,000
-61.8%
25,795
-46.3%
0.00%
Q2 2022$152,000
+7.8%
48,026
+63.4%
0.00%
Q1 2022$141,000
-63.7%
29,392
-32.3%
0.00%
Q4 2021$388,000
-23.2%
43,439
+24.1%
0.00%
Q3 2021$505,000
+2.9%
34,990
+3.0%
0.00%
Q2 2021$491,000
+41.1%
33,976
+33.6%
0.00%
Q1 2021$348,000
-40.6%
25,431
+25.7%
0.00%
Q4 2020$586,00020,2340.00%
Other shareholders
SQZ BIOTECHNOLOGIES CO shareholders Q3 2022
NameSharesValueWeighting ↓
Artal Group S.A. 1,606,309$1290.01%
AMERICAN INTERNATIONAL GROUP, INC. 2,517,173$202,0030.00%
Bangor Savings Bank 11,357$9110.00%
Blue Trust, Inc. 4,195$10.00%
BARCLAYS PLC 1,794$00.00%
View complete list of SQZ BIOTECHNOLOGIES CO shareholders